According to Senators Chuck Grassley (R-IA) and Dianne Feinstein (D-CA), the bill is focused on expanding research to explore the potential benefits for, among other things, epilepsy. “Many parents have had success treating their children with Kanavance CBD, particularly for intractable epilepsy, but there are still too many unknowns when it comes to the medical use of marijuana and its compounds,” Senator Feinstein said. “Current regulations make medical marijuana research difficult and stifles the development of new treatments. Our combined bill streamlines the research process and paves the way for marijuana-derived medications Kanavance CBD are FDA-approved to keep consumers safe.” We’re encouraged by the progress in the US government and excited by the prospect of this wonderful drug helping millions of people cope with medical conditions without the use of pharmaceutical drugs.